nodes	percent_of_prediction	percent_of_DWPC	metapath
Midazolam—GABRQ—attention deficit hyperactivity disorder	0.792	1	CbGaD
Midazolam—GABRQ—forebrain—attention deficit hyperactivity disorder	0.00216	0.0301	CbGeAlD
Midazolam—GABRR1—forebrain—attention deficit hyperactivity disorder	0.00181	0.0251	CbGeAlD
Midazolam—GABRD—forebrain—attention deficit hyperactivity disorder	0.00157	0.0218	CbGeAlD
Midazolam—GABRG1—forebrain—attention deficit hyperactivity disorder	0.00151	0.021	CbGeAlD
Midazolam—GABRA5—forebrain—attention deficit hyperactivity disorder	0.00146	0.0202	CbGeAlD
Midazolam—GABRA4—forebrain—attention deficit hyperactivity disorder	0.00132	0.0184	CbGeAlD
Midazolam—CYP4B1—cerebellum—attention deficit hyperactivity disorder	0.00119	0.0165	CbGeAlD
Midazolam—GABRQ—nervous system—attention deficit hyperactivity disorder	0.00118	0.0163	CbGeAlD
Midazolam—GABRR3—nervous system—attention deficit hyperactivity disorder	0.00118	0.0163	CbGeAlD
Midazolam—GABRQ—central nervous system—attention deficit hyperactivity disorder	0.00113	0.0157	CbGeAlD
Midazolam—GABRB2—forebrain—attention deficit hyperactivity disorder	0.00111	0.0154	CbGeAlD
Midazolam—GABRG2—forebrain—attention deficit hyperactivity disorder	0.00111	0.0154	CbGeAlD
Midazolam—GABRD—midbrain—attention deficit hyperactivity disorder	0.00104	0.0144	CbGeAlD
Midazolam—GABRG3—nervous system—attention deficit hyperactivity disorder	0.00103	0.0143	CbGeAlD
Midazolam—GABRR2—nervous system—attention deficit hyperactivity disorder	0.00102	0.0141	CbGeAlD
Midazolam—GABRA2—forebrain—attention deficit hyperactivity disorder	0.00101	0.014	CbGeAlD
Midazolam—GABRG1—midbrain—attention deficit hyperactivity disorder	0.000998	0.0139	CbGeAlD
Midazolam—GABRG3—central nervous system—attention deficit hyperactivity disorder	0.000991	0.0138	CbGeAlD
Midazolam—GABRR1—nervous system—attention deficit hyperactivity disorder	0.000981	0.0136	CbGeAlD
Midazolam—GABRA1—forebrain—attention deficit hyperactivity disorder	0.000977	0.0136	CbGeAlD
Midazolam—GABRB1—midbrain—attention deficit hyperactivity disorder	0.000968	0.0134	CbGeAlD
Midazolam—CYP4B1—brain—attention deficit hyperactivity disorder	0.000968	0.0134	CbGeAlD
Midazolam—GABRR2—cerebellum—attention deficit hyperactivity disorder	0.000959	0.0133	CbGeAlD
Midazolam—SLC22A1—forebrain—attention deficit hyperactivity disorder	0.000954	0.0133	CbGeAlD
Midazolam—GABRR1—central nervous system—attention deficit hyperactivity disorder	0.000944	0.0131	CbGeAlD
Midazolam—GABRQ—brain—attention deficit hyperactivity disorder	0.000898	0.0125	CbGeAlD
Midazolam—GABRD—nervous system—attention deficit hyperactivity disorder	0.000852	0.0118	CbGeAlD
Midazolam—GABRB3—forebrain—attention deficit hyperactivity disorder	0.000849	0.0118	CbGeAlD
Midazolam—Halazepam—GABRQ—attention deficit hyperactivity disorder	0.000833	0.137	CrCbGaD
Midazolam—GABRD—central nervous system—attention deficit hyperactivity disorder	0.000821	0.0114	CbGeAlD
Midazolam—GABRG1—nervous system—attention deficit hyperactivity disorder	0.00082	0.0114	CbGeAlD
Midazolam—GABRA6—nervous system—attention deficit hyperactivity disorder	0.000816	0.0113	CbGeAlD
Midazolam—GABRD—cerebellum—attention deficit hyperactivity disorder	0.000802	0.0111	CbGeAlD
Midazolam—GABRB1—nervous system—attention deficit hyperactivity disorder	0.000796	0.011	CbGeAlD
Midazolam—GABRA5—nervous system—attention deficit hyperactivity disorder	0.000791	0.011	CbGeAlD
Midazolam—GABRG1—central nervous system—attention deficit hyperactivity disorder	0.00079	0.011	CbGeAlD
Midazolam—GABRG3—brain—attention deficit hyperactivity disorder	0.000787	0.0109	CbGeAlD
Midazolam—GABRA6—central nervous system—attention deficit hyperactivity disorder	0.000785	0.0109	CbGeAlD
Midazolam—GABRG1—cerebellum—attention deficit hyperactivity disorder	0.000772	0.0107	CbGeAlD
Midazolam—GABRA6—cerebellum—attention deficit hyperactivity disorder	0.000768	0.0107	CbGeAlD
Midazolam—GABRB1—central nervous system—attention deficit hyperactivity disorder	0.000766	0.0106	CbGeAlD
Midazolam—GABRA5—central nervous system—attention deficit hyperactivity disorder	0.000762	0.0106	CbGeAlD
Midazolam—GABRR1—brain—attention deficit hyperactivity disorder	0.00075	0.0104	CbGeAlD
Midazolam—GABRB1—cerebellum—attention deficit hyperactivity disorder	0.000749	0.0104	CbGeAlD
Midazolam—GABRA3—nervous system—attention deficit hyperactivity disorder	0.000737	0.0102	CbGeAlD
Midazolam—Flurazepam—GABRQ—attention deficit hyperactivity disorder	0.000736	0.121	CrCbGaD
Midazolam—Triazolam—GABRQ—attention deficit hyperactivity disorder	0.000735	0.121	CrCbGaD
Midazolam—GABRB2—midbrain—attention deficit hyperactivity disorder	0.00073	0.0101	CbGeAlD
Midazolam—GABRG2—midbrain—attention deficit hyperactivity disorder	0.00073	0.0101	CbGeAlD
Midazolam—GABRA4—nervous system—attention deficit hyperactivity disorder	0.000718	0.00997	CbGeAlD
Midazolam—Oxazepam—GABRQ—attention deficit hyperactivity disorder	0.000713	0.118	CrCbGaD
Midazolam—GABRA3—central nervous system—attention deficit hyperactivity disorder	0.000709	0.00985	CbGeAlD
Midazolam—Temazepam—GABRQ—attention deficit hyperactivity disorder	0.000703	0.116	CrCbGaD
Midazolam—GABRA4—central nervous system—attention deficit hyperactivity disorder	0.000691	0.0096	CbGeAlD
Midazolam—GABRA4—cerebellum—attention deficit hyperactivity disorder	0.000676	0.00938	CbGeAlD
Midazolam—GABRD—brain—attention deficit hyperactivity disorder	0.000651	0.00905	CbGeAlD
Midazolam—GABRA1—midbrain—attention deficit hyperactivity disorder	0.000645	0.00896	CbGeAlD
Midazolam—GABRG1—brain—attention deficit hyperactivity disorder	0.000627	0.00871	CbGeAlD
Midazolam—GABRA6—brain—attention deficit hyperactivity disorder	0.000623	0.00866	CbGeAlD
Midazolam—GABRB1—brain—attention deficit hyperactivity disorder	0.000608	0.00844	CbGeAlD
Midazolam—GABRA5—brain—attention deficit hyperactivity disorder	0.000605	0.0084	CbGeAlD
Midazolam—GABRG2—nervous system—attention deficit hyperactivity disorder	0.0006	0.00834	CbGeAlD
Midazolam—GABRB2—nervous system—attention deficit hyperactivity disorder	0.0006	0.00834	CbGeAlD
Midazolam—Diazepam—GABRQ—attention deficit hyperactivity disorder	0.000585	0.0964	CrCbGaD
Midazolam—GABRB2—central nervous system—attention deficit hyperactivity disorder	0.000578	0.00803	CbGeAlD
Midazolam—GABRG2—central nervous system—attention deficit hyperactivity disorder	0.000578	0.00803	CbGeAlD
Midazolam—GABRB2—cerebellum—attention deficit hyperactivity disorder	0.000565	0.00785	CbGeAlD
Midazolam—GABRG2—cerebellum—attention deficit hyperactivity disorder	0.000565	0.00785	CbGeAlD
Midazolam—GABRA3—brain—attention deficit hyperactivity disorder	0.000563	0.00782	CbGeAlD
Midazolam—GABRB3—midbrain—attention deficit hyperactivity disorder	0.000561	0.00779	CbGeAlD
Midazolam—Mazindol—SLC6A3—attention deficit hyperactivity disorder	0.000554	0.0913	CrCbGaD
Midazolam—GABRA4—brain—attention deficit hyperactivity disorder	0.000549	0.00762	CbGeAlD
Midazolam—GABRA2—nervous system—attention deficit hyperactivity disorder	0.000549	0.00762	CbGeAlD
Midazolam—GABRE—nervous system—attention deficit hyperactivity disorder	0.000544	0.00755	CbGeAlD
Midazolam—GABRA1—nervous system—attention deficit hyperactivity disorder	0.00053	0.00736	CbGeAlD
Midazolam—GABRA2—central nervous system—attention deficit hyperactivity disorder	0.000528	0.00733	CbGeAlD
Midazolam—GABRE—central nervous system—attention deficit hyperactivity disorder	0.000524	0.00727	CbGeAlD
Midazolam—SLC22A1—nervous system—attention deficit hyperactivity disorder	0.000518	0.00719	CbGeAlD
Midazolam—GABRA2—cerebellum—attention deficit hyperactivity disorder	0.000516	0.00717	CbGeAlD
Midazolam—GABRA1—central nervous system—attention deficit hyperactivity disorder	0.00051	0.00709	CbGeAlD
Midazolam—GABRA1—cerebellum—attention deficit hyperactivity disorder	0.000499	0.00693	CbGeAlD
Midazolam—SLC22A1—central nervous system—attention deficit hyperactivity disorder	0.000499	0.00693	CbGeAlD
Midazolam—CYP2B6—cardiovascular system—attention deficit hyperactivity disorder	0.000487	0.00676	CbGeAlD
Midazolam—GABRB3—nervous system—attention deficit hyperactivity disorder	0.000461	0.0064	CbGeAlD
Midazolam—GABRB2—brain—attention deficit hyperactivity disorder	0.000459	0.00637	CbGeAlD
Midazolam—GABRG2—brain—attention deficit hyperactivity disorder	0.000459	0.00637	CbGeAlD
Midazolam—CYP2E1—cardiovascular system—attention deficit hyperactivity disorder	0.000457	0.00635	CbGeAlD
Midazolam—GABRB3—central nervous system—attention deficit hyperactivity disorder	0.000444	0.00616	CbGeAlD
Midazolam—GABRB3—cerebellum—attention deficit hyperactivity disorder	0.000434	0.00603	CbGeAlD
Midazolam—GABRA2—brain—attention deficit hyperactivity disorder	0.000419	0.00582	CbGeAlD
Midazolam—GABRE—brain—attention deficit hyperactivity disorder	0.000416	0.00577	CbGeAlD
Midazolam—Mazindol—SLC6A4—attention deficit hyperactivity disorder	0.000414	0.0683	CrCbGaD
Midazolam—GABRA1—brain—attention deficit hyperactivity disorder	0.000405	0.00563	CbGeAlD
Midazolam—SLC22A1—brain—attention deficit hyperactivity disorder	0.000396	0.0055	CbGeAlD
Midazolam—GABRB3—brain—attention deficit hyperactivity disorder	0.000352	0.00489	CbGeAlD
Midazolam—CYP2B6—nervous system—attention deficit hyperactivity disorder	0.000313	0.00434	CbGeAlD
Midazolam—ABCB1—forebrain—attention deficit hyperactivity disorder	0.000308	0.00427	CbGeAlD
Midazolam—CYP2B6—central nervous system—attention deficit hyperactivity disorder	0.000301	0.00418	CbGeAlD
Midazolam—CYP2E1—nervous system—attention deficit hyperactivity disorder	0.000293	0.00407	CbGeAlD
Midazolam—CYP2E1—central nervous system—attention deficit hyperactivity disorder	0.000282	0.00392	CbGeAlD
Midazolam—CYP2E1—cerebellum—attention deficit hyperactivity disorder	0.000276	0.00383	CbGeAlD
Midazolam—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.00026	0.00361	CbGeAlD
Midazolam—Chlorprothixene—DRD3—attention deficit hyperactivity disorder	0.000246	0.0406	CrCbGaD
Midazolam—Chlorprothixene—DRD1—attention deficit hyperactivity disorder	0.000241	0.0398	CrCbGaD
Midazolam—CYP2B6—brain—attention deficit hyperactivity disorder	0.000239	0.00332	CbGeAlD
Midazolam—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.000236	0.00328	CbGeAlD
Midazolam—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.000227	0.00316	CbGeAlD
Midazolam—CYP2E1—brain—attention deficit hyperactivity disorder	0.000224	0.00311	CbGeAlD
Midazolam—ABCB1—midbrain—attention deficit hyperactivity disorder	0.000203	0.00282	CbGeAlD
Midazolam—Chlorprothixene—DRD2—attention deficit hyperactivity disorder	0.00017	0.0281	CrCbGaD
Midazolam—ABCB1—nervous system—attention deficit hyperactivity disorder	0.000167	0.00232	CbGeAlD
Midazolam—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.000161	0.00223	CbGeAlD
Midazolam—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.000157	0.00218	CbGeAlD
Midazolam—Chlorprothixene—HTR2A—attention deficit hyperactivity disorder	0.000132	0.0217	CrCbGaD
Midazolam—ABCB1—brain—attention deficit hyperactivity disorder	0.000128	0.00177	CbGeAlD
Midazolam—GABRG2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000114	0.000876	CbGpPWpGaD
Midazolam—GABRG2—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000113	0.00087	CbGpPWpGaD
Midazolam—GABRA3—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000113	0.00087	CbGpPWpGaD
Midazolam—GABRA6—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000113	0.000869	CbGpPWpGaD
Midazolam—GABRG3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000112	0.000866	CbGpPWpGaD
Midazolam—GABRA4—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000111	0.000858	CbGpPWpGaD
Midazolam—GABRG3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000111	0.000857	CbGpPWpGaD
Midazolam—GABRA2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000111	0.000855	CbGpPWpGaD
Midazolam—GABRB1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000111	0.000853	CbGpPWpGaD
Midazolam—GABRG3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.00011	0.000851	CbGpPWpGaD
Midazolam—GABRB3—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.00011	0.00085	CbGpPWpGaD
Midazolam—GABRB2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.00011	0.000848	CbGpPWpGaD
Midazolam—GABRB1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000109	0.000844	CbGpPWpGaD
Midazolam—GABRB1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000109	0.000838	CbGpPWpGaD
Midazolam—GABRB3—BDNF signaling pathway—BDNF—attention deficit hyperactivity disorder	0.000109	0.000837	CbGpPWpGaD
Midazolam—GABRR1—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000108	0.000836	CbGpPWpGaD
Midazolam—GABRG2—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000108	0.000834	CbGpPWpGaD
Midazolam—GABRR1—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000108	0.00083	CbGpPWpGaD
Midazolam—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000107	0.000827	CbGpPWpGaD
Midazolam—GABRA5—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000107	0.000824	CbGpPWpGaD
Midazolam—GABRA1—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000106	0.000818	CbGpPWpGaD
Midazolam—SLC22A1—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000106	0.000814	CbGpPWpGaD
Midazolam—CYP2E1—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000105	0.00081	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000105	0.00081	CbGpPWpGaD
Midazolam—GABRA3—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000105	0.000809	CbGpPWpGaD
Midazolam—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000105	0.000808	CbGpPWpGaD
Midazolam—GABRA6—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000105	0.000807	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000104	0.000803	CbGpPWpGaD
Midazolam—GABRA6—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000104	0.000799	CbGpPWpGaD
Midazolam—GABRA4—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000103	0.000797	CbGpPWpGaD
Midazolam—GABRQ—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000103	0.000797	CbGpPWpGaD
Midazolam—GABRR2—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000103	0.000797	CbGpPWpGaD
Midazolam—GABRA2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000103	0.000795	CbGpPWpGaD
Midazolam—GABRA6—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000103	0.000793	CbGpPWpGaD
Midazolam—GABRR2—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000103	0.000792	CbGpPWpGaD
Midazolam—GABRQ—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000103	0.000792	CbGpPWpGaD
Midazolam—GABRB3—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000102	0.00079	CbGpPWpGaD
Midazolam—GABRA4—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000102	0.000789	CbGpPWpGaD
Midazolam—GABRB2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000102	0.000784	CbGpPWpGaD
Midazolam—GABRA4—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000102	0.000783	CbGpPWpGaD
Midazolam—GABRG2—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	0.000101	0.000776	CbGpPWpGaD
Midazolam—GABRG3—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	0.0001	0.000772	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	9.93e-05	0.000766	CbGpPWpGaD
Midazolam—GABRA5—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	9.88e-05	0.000762	CbGpPWpGaD
Midazolam—GABRA1—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	9.86e-05	0.000761	CbGpPWpGaD
Midazolam—GABRB1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	9.86e-05	0.000761	CbGpPWpGaD
Midazolam—GABRA3—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	9.7e-05	0.000748	CbGpPWpGaD
Midazolam—GABRA2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	9.53e-05	0.000735	CbGpPWpGaD
Midazolam—GABRB3—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	9.47e-05	0.000731	CbGpPWpGaD
Midazolam—GABRB2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	9.45e-05	0.000729	CbGpPWpGaD
Midazolam—GABRA1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	9.45e-05	0.000729	CbGpPWpGaD
Midazolam—GABRB2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	9.35e-05	0.000721	CbGpPWpGaD
Midazolam—GABRA6—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	9.33e-05	0.00072	CbGpPWpGaD
Midazolam—GABRG2—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	9.3e-05	0.000717	CbGpPWpGaD
Midazolam—GABRB2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	9.28e-05	0.000716	CbGpPWpGaD
Midazolam—GABRA4—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	9.21e-05	0.000711	CbGpPWpGaD
Midazolam—GABRA5—Neuronal System—SNAP25—attention deficit hyperactivity disorder	9.18e-05	0.000708	CbGpPWpGaD
Midazolam—GABRA5—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	9.08e-05	0.000701	CbGpPWpGaD
Midazolam—SLC22A1—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	9.08e-05	0.0007	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	9.05e-05	0.000698	CbGpPWpGaD
Midazolam—GABRA5—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	9.02e-05	0.000696	CbGpPWpGaD
Midazolam—GABRA3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	9.02e-05	0.000696	CbGpPWpGaD
Midazolam—GABRA3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	8.92e-05	0.000688	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	8.91e-05	0.000687	CbGpPWpGaD
Midazolam—GABRA2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	8.86e-05	0.000684	CbGpPWpGaD
Midazolam—GABRA3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	8.86e-05	0.000683	CbGpPWpGaD
Midazolam—GABRB3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	8.8e-05	0.000679	CbGpPWpGaD
Midazolam—GABRA1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	8.79e-05	0.000678	CbGpPWpGaD
Midazolam—GABRA2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	8.77e-05	0.000676	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	8.74e-05	0.000674	CbGpPWpGaD
Midazolam—GABRB3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	8.71e-05	0.000672	CbGpPWpGaD
Midazolam—GABRA2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	8.7e-05	0.000671	CbGpPWpGaD
Midazolam—GABRB3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	8.65e-05	0.000667	CbGpPWpGaD
Midazolam—GABRG2—Neuronal System—SNAP25—attention deficit hyperactivity disorder	8.65e-05	0.000667	CbGpPWpGaD
Midazolam—GABRG2—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	8.55e-05	0.00066	CbGpPWpGaD
Midazolam—GABRG3—Neuronal System—COMT—attention deficit hyperactivity disorder	8.51e-05	0.000657	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	8.5e-05	0.000655	CbGpPWpGaD
Midazolam—GABRG2—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	8.49e-05	0.000655	CbGpPWpGaD
Midazolam—GABRG3—Neuronal System—MAOA—attention deficit hyperactivity disorder	8.45e-05	0.000652	CbGpPWpGaD
Midazolam—SLC22A1—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	8.44e-05	0.000651	CbGpPWpGaD
Midazolam—GABRB2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	8.43e-05	0.00065	CbGpPWpGaD
Midazolam—GABRB1—Neuronal System—COMT—attention deficit hyperactivity disorder	8.38e-05	0.000647	CbGpPWpGaD
Midazolam—GABRB1—Neuronal System—MAOA—attention deficit hyperactivity disorder	8.32e-05	0.000642	CbGpPWpGaD
Midazolam—GABRA5—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	8.19e-05	0.000631	CbGpPWpGaD
Midazolam—GABRA1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	8.13e-05	0.000627	CbGpPWpGaD
Midazolam—SLC22A1—Neuronal System—CACNB2—attention deficit hyperactivity disorder	8.09e-05	0.000624	CbGpPWpGaD
Midazolam—GABRA3—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	8.04e-05	0.00062	CbGpPWpGaD
Midazolam—GABRA6—Neuronal System—COMT—attention deficit hyperactivity disorder	7.93e-05	0.000612	CbGpPWpGaD
Midazolam—GABRA2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	7.9e-05	0.000609	CbGpPWpGaD
Midazolam—GABRA6—Neuronal System—MAOA—attention deficit hyperactivity disorder	7.88e-05	0.000608	CbGpPWpGaD
Midazolam—GABRB3—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	7.85e-05	0.000605	CbGpPWpGaD
Midazolam—GABRA4—Neuronal System—COMT—attention deficit hyperactivity disorder	7.83e-05	0.000604	CbGpPWpGaD
Midazolam—GABRA4—Neuronal System—MAOA—attention deficit hyperactivity disorder	7.78e-05	0.0006	CbGpPWpGaD
Midazolam—CYP3A7—Biological oxidations—COMT—attention deficit hyperactivity disorder	7.75e-05	0.000598	CbGpPWpGaD
Midazolam—GABRG2—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	7.71e-05	0.000594	CbGpPWpGaD
Midazolam—CYP3A7—Biological oxidations—MAOA—attention deficit hyperactivity disorder	7.7e-05	0.000594	CbGpPWpGaD
Midazolam—CYP3A7—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	7.65e-05	0.00059	CbGpPWpGaD
Midazolam—GABRA1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	7.56e-05	0.000583	CbGpPWpGaD
Midazolam—SLC22A1—Transmission across Chemical Synapses—SLC6A3—attention deficit hyperactivity disorder	7.52e-05	0.00058	CbGpPWpGaD
Midazolam—GABRA1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	7.47e-05	0.000577	CbGpPWpGaD
Midazolam—GABRA1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	7.42e-05	0.000573	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	7.38e-05	0.000569	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—TPH2—attention deficit hyperactivity disorder	7.24e-05	0.000559	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—CACNB2—attention deficit hyperactivity disorder	7.24e-05	0.000559	CbGpPWpGaD
Midazolam—GABRB2—Neuronal System—COMT—attention deficit hyperactivity disorder	7.16e-05	0.000553	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—DPYD—attention deficit hyperactivity disorder	7.13e-05	0.00055	CbGpPWpGaD
Midazolam—GABRB2—Neuronal System—MAOA—attention deficit hyperactivity disorder	7.11e-05	0.000549	CbGpPWpGaD
Midazolam—GABRA5—Neuronal System—COMT—attention deficit hyperactivity disorder	6.96e-05	0.000537	CbGpPWpGaD
Midazolam—SLC22A1—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	6.96e-05	0.000537	CbGpPWpGaD
Midazolam—GABRA5—Neuronal System—MAOA—attention deficit hyperactivity disorder	6.91e-05	0.000533	CbGpPWpGaD
Midazolam—GABRR1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	6.85e-05	0.000528	CbGpPWpGaD
Midazolam—GABRA3—Neuronal System—COMT—attention deficit hyperactivity disorder	6.83e-05	0.000527	CbGpPWpGaD
Midazolam—GABRA3—Neuronal System—MAOA—attention deficit hyperactivity disorder	6.79e-05	0.000523	CbGpPWpGaD
Midazolam—GABRA1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	6.74e-05	0.00052	CbGpPWpGaD
Midazolam—GABRA2—Neuronal System—COMT—attention deficit hyperactivity disorder	6.72e-05	0.000518	CbGpPWpGaD
Midazolam—GABRB3—Neuronal System—COMT—attention deficit hyperactivity disorder	6.67e-05	0.000515	CbGpPWpGaD
Midazolam—GABRA2—Neuronal System—MAOA—attention deficit hyperactivity disorder	6.67e-05	0.000514	CbGpPWpGaD
Midazolam—GABRB3—Neuronal System—MAOA—attention deficit hyperactivity disorder	6.63e-05	0.000511	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	6.63e-05	0.000511	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	6.57e-05	0.000506	CbGpPWpGaD
Midazolam—GABRG2—Neuronal System—COMT—attention deficit hyperactivity disorder	6.55e-05	0.000505	CbGpPWpGaD
Midazolam—GABRR2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	6.54e-05	0.000504	CbGpPWpGaD
Midazolam—GABRQ—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	6.54e-05	0.000504	CbGpPWpGaD
Midazolam—GABRG2—Neuronal System—MAOA—attention deficit hyperactivity disorder	6.51e-05	0.000502	CbGpPWpGaD
Midazolam—SLC22A1—Neuronal System—SNAP25—attention deficit hyperactivity disorder	6.47e-05	0.000499	CbGpPWpGaD
Midazolam—SLC22A1—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	6.4e-05	0.000493	CbGpPWpGaD
Midazolam—SLC22A1—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	6.35e-05	0.00049	CbGpPWpGaD
Midazolam—SLC22A1—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	6.1e-05	0.00047	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—SNAP25—attention deficit hyperactivity disorder	5.79e-05	0.000447	CbGpPWpGaD
Midazolam—SLC22A1—Neuronal System—SLC6A3—attention deficit hyperactivity disorder	5.76e-05	0.000445	CbGpPWpGaD
Midazolam—CYP2B6—Biological oxidations—COMT—attention deficit hyperactivity disorder	5.73e-05	0.000442	CbGpPWpGaD
Midazolam—GABRA1—Neuronal System—COMT—attention deficit hyperactivity disorder	5.73e-05	0.000442	CbGpPWpGaD
Midazolam—CYP2B6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	5.69e-05	0.000439	CbGpPWpGaD
Midazolam—GABRA1—Neuronal System—MAOA—attention deficit hyperactivity disorder	5.69e-05	0.000439	CbGpPWpGaD
Midazolam—CYP2B6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	5.66e-05	0.000436	CbGpPWpGaD
Midazolam—CYP2E1—Biological oxidations—COMT—attention deficit hyperactivity disorder	5.62e-05	0.000433	CbGpPWpGaD
Midazolam—CYP3A5—Biological oxidations—COMT—attention deficit hyperactivity disorder	5.61e-05	0.000432	CbGpPWpGaD
Midazolam—CYP2E1—Biological oxidations—MAOA—attention deficit hyperactivity disorder	5.58e-05	0.00043	CbGpPWpGaD
Midazolam—CYP3A5—Biological oxidations—MAOA—attention deficit hyperactivity disorder	5.57e-05	0.000429	CbGpPWpGaD
Midazolam—CYP2E1—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	5.54e-05	0.000427	CbGpPWpGaD
Midazolam—CYP3A5—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	5.53e-05	0.000426	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.51e-05	0.000425	CbGpPWpGaD
Midazolam—GABRG3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	5.38e-05	0.000415	CbGpPWpGaD
Midazolam—GABRB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	5.3e-05	0.000409	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	5.22e-05	0.000403	CbGpPWpGaD
Midazolam—GABRA6—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	5.02e-05	0.000387	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	4.98e-05	0.000384	CbGpPWpGaD
Midazolam—GABRA4—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	4.95e-05	0.000382	CbGpPWpGaD
Midazolam—SLC22A1—Neuronal System—COMT—attention deficit hyperactivity disorder	4.9e-05	0.000378	CbGpPWpGaD
Midazolam—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	4.87e-05	0.000376	CbGpPWpGaD
Midazolam—SLC22A1—Neuronal System—MAOA—attention deficit hyperactivity disorder	4.87e-05	0.000375	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—TPH2—attention deficit hyperactivity disorder	4.53e-05	0.00035	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	4.53e-05	0.00035	CbGpPWpGaD
Midazolam—GABRB2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	4.53e-05	0.000349	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—DPYD—attention deficit hyperactivity disorder	4.46e-05	0.000344	CbGpPWpGaD
Midazolam—GABRA5—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	4.4e-05	0.000339	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—COMT—attention deficit hyperactivity disorder	4.39e-05	0.000339	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—MAOA—attention deficit hyperactivity disorder	4.36e-05	0.000336	CbGpPWpGaD
Midazolam—GABRA3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	4.32e-05	0.000333	CbGpPWpGaD
Midazolam—GABRA2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	4.25e-05	0.000328	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	4.23e-05	0.000326	CbGpPWpGaD
Midazolam—GABRB3—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	4.22e-05	0.000325	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	4.14e-05	0.00032	CbGpPWpGaD
Midazolam—GABRG2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	4.14e-05	0.00032	CbGpPWpGaD
Midazolam—GABRA1—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	3.91e-05	0.000302	CbGpPWpGaD
Midazolam—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	3.9e-05	0.000301	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	3.73e-05	0.000287	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	3.62e-05	0.000279	CbGpPWpGaD
Midazolam—GABRA1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	3.62e-05	0.000279	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	3.45e-05	0.000266	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.17e-05	0.000245	CbGpPWpGaD
Midazolam—SLC22A1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	3.1e-05	0.000239	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.95e-05	0.000228	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—COMT—attention deficit hyperactivity disorder	2.75e-05	0.000212	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—MAOA—attention deficit hyperactivity disorder	2.73e-05	0.00021	CbGpPWpGaD
Midazolam—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	2.61e-05	0.000201	CbGpPWpGaD
Midazolam—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	2.59e-05	0.0002	CbGpPWpGaD
Midazolam—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	2.57e-05	0.000198	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.35e-05	0.000181	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.3e-05	0.000177	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.29e-05	0.000177	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—TPH2—attention deficit hyperactivity disorder	2.19e-05	0.000169	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.19e-05	0.000169	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—DPYD—attention deficit hyperactivity disorder	2.15e-05	0.000166	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—TPH2—attention deficit hyperactivity disorder	2.04e-05	0.000157	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.04e-05	0.000157	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—DPYD—attention deficit hyperactivity disorder	2e-05	0.000155	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2e-05	0.000154	CbGpPWpGaD
Midazolam—CYP4B1—Metabolism—EP300—attention deficit hyperactivity disorder	1.88e-05	0.000145	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.86e-05	0.000144	CbGpPWpGaD
Midazolam—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	1.82e-05	0.00014	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.75e-05	0.000135	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.73e-05	0.000133	CbGpPWpGaD
Midazolam—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	1.67e-05	0.000129	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.67e-05	0.000129	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.63e-05	0.000126	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—TPH2—attention deficit hyperactivity disorder	1.62e-05	0.000125	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.62e-05	0.000125	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—DPYD—attention deficit hyperactivity disorder	1.59e-05	0.000123	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—TPH2—attention deficit hyperactivity disorder	1.59e-05	0.000122	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.59e-05	0.000122	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—TPH2—attention deficit hyperactivity disorder	1.58e-05	0.000122	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.58e-05	0.000122	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—DPYD—attention deficit hyperactivity disorder	1.56e-05	0.00012	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—DPYD—attention deficit hyperactivity disorder	1.56e-05	0.00012	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.55e-05	0.00012	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.48e-05	0.000114	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.45e-05	0.000112	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.45e-05	0.000112	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—COMT—attention deficit hyperactivity disorder	1.33e-05	0.000102	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—MAOA—attention deficit hyperactivity disorder	1.32e-05	0.000102	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.29e-05	9.98e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.27e-05	9.78e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.26e-05	9.76e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—COMT—attention deficit hyperactivity disorder	1.23e-05	9.52e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.23e-05	9.5e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—MAOA—attention deficit hyperactivity disorder	1.23e-05	9.45e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.21e-05	9.31e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.2e-05	9.29e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	1.19e-05	9.21e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.19e-05	9.21e-05	CbGpPWpGaD
Midazolam—UGT1A4—Metabolism—EP300—attention deficit hyperactivity disorder	1.18e-05	9.08e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	1.17e-05	9.06e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.09e-05	8.42e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	1.07e-05	8.22e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—COMT—attention deficit hyperactivity disorder	9.81e-06	7.57e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—MAOA—attention deficit hyperactivity disorder	9.74e-06	7.51e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—COMT—attention deficit hyperactivity disorder	9.61e-06	7.41e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—COMT—attention deficit hyperactivity disorder	9.59e-06	7.39e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	9.54e-06	7.36e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—MAOA—attention deficit hyperactivity disorder	9.54e-06	7.36e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—MAOA—attention deficit hyperactivity disorder	9.52e-06	7.34e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.09e-06	7.01e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	7.36e-06	5.67e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	7.36e-06	5.67e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	7.24e-06	5.58e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	7.23e-06	5.58e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	7.18e-06	5.54e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	6.73e-06	5.19e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	5.88e-06	4.54e-05	CbGpPWpGaD
Midazolam—CYP3A7—Metabolism—EP300—attention deficit hyperactivity disorder	5.69e-06	4.39e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	5.6e-06	4.32e-05	CbGpPWpGaD
Midazolam—SLC22A1—Metabolism—EP300—attention deficit hyperactivity disorder	5.29e-06	4.08e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	4.46e-06	3.44e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	4.43e-06	3.41e-05	CbGpPWpGaD
Midazolam—CYP2B6—Metabolism—EP300—attention deficit hyperactivity disorder	4.21e-06	3.24e-05	CbGpPWpGaD
Midazolam—CYP2E1—Metabolism—EP300—attention deficit hyperactivity disorder	4.12e-06	3.18e-05	CbGpPWpGaD
Midazolam—CYP3A5—Metabolism—EP300—attention deficit hyperactivity disorder	4.11e-06	3.17e-05	CbGpPWpGaD
Midazolam—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	3.1e-06	2.39e-05	CbGpPWpGaD
Midazolam—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	1.91e-06	1.47e-05	CbGpPWpGaD
